Erratum: Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: Community cross-sectional and case-control studies (American Journal of Gastroenterology (2010) 105 (624-631) DOI:10.1038/ajg.2009.711);Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: Community cross-sectional and case-control studies

American Journal of Gastroenterology

Volumn 105, Issue 3, 2010, Pages 624-631

  Tung, Hung Da ^a,b   Wang, Jing Houng ^a   Tseng, Po Lin ^a   Hung, Chao Hung ^a   Kee, Kwong Ming ^a   Chen, Chien Hung ^a   Chang, Kuo Chin ^a   Lee, Chuan Mo ^a   Changchien, Chi Sin ^a   Chen, Yao Der ^c   Lu, Sheng Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c DEPARTMENT OF HEALTH   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; CHOLESTEROL; GLUCOSE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; CANCER DIAGNOSIS; CANCER SCREENING; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TAIWAN; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77949261460     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.208     Document Type: Erratum

References (50)

1. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer:worldwide incidence of trends. Gastroenterology 2004;127 (5 Suppl 1):S5-16.
2. Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006;19:1946-1952
3. Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res 2007;37 (Suppl 2):S101-5.
4. Kiyosawa K, Umemura T, Ichijo T, et al. Hepatocellular carcinoma:recent trends in Japan. Gastroenterology 2004;127 (5 Suppl 1):S17-26.
5. El-Serag HB. Hepatocellular carcinoma:recent trends in the United States. Gastroenterology 2004;127 (5 Suppl 1):S27-34.
6. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systemic review. Br J Cancer 2007;96:1127-1134
7. Nair S, Mason A, Eason J, et al. Is obesity an independent risk factor of hepatocellular carcinoma in cirrhosis? Hepatology 2002;36:150-155
8. Lai MS, Hsieh MS, Chiu YH, et al. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295-1302
9. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma:a case-control study among United States veterans. Am J Gastroenterol 2001;96:2462-2467
10. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma:synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-1213
11. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468
12. Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the United States:a population based case control study. Gut 2005;54:533-539
13. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma:a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006;4:369-380
14. Bugianesi E, Leone N, Vanni E, et al. Expanding the nature history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140
15. Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma. Gastroenterology 2004;127 (5 Suppl 1):S97-103.
16. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127 (5 Suppl 1): S35-50.
17. Shimada M, Hashimoto E, Taniai M, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-160
18. Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-1354
19. Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med 2007;120:828-834
20. Lecube A, Hern á ndez C, Genesc à J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection:epidemiology and pathogenesis. Diabetes Care 2006;29:1140-1149
21. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection:a follow-up study in Taiwan. Gastroenterology 2008;135:111-121
22. Tsai MC, Kee KM, Chen YD, et al. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country:geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol 2007;22:92-98
23. Lu SN, Wang JH, Liu SL, et al. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 2006;107:2212-2222
24. Lu SN, Wang JH, Chen PF, et al. Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults. Cancer Epidemiol Biomarkers Prev 2008;17:1813-1821
25. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430
26. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526
27. Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-1382
28. StreiffMB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 2002;35:947-952
29. Qamar AA, Grace ND, Groszmann RJ, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009;7:689-695
30. Hjalgrim H, Frisch M, Ekbom A, et al. Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997;241:471-475
31. WideroffL, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-1365
32. Ragozzino M, Melton LJ III, Chu CP, et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-19
33. Lu SN, Lin TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-2055
34. Strauss R, T ö rner A, Duberg AS, et al. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden-a low endemic country. J Viral Hepat 2008;15:531-537
35. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-333
36. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United Stages. Ann Intern Med 2000;133:592-599
37. Wang CS, Wang ST, Yao WJ, et al. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 2007;166:196-203.
38. Petrides AS, Vogt C, Schulze-Berge D, et al. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-627
39. Gentile S, Loguercio C, Marmo R, et al. Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993;22:37-44.
40. Veldt BJ, Chen W, Heathcote EJ, et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008;47:1856-1862
41. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastrolenterol Hepatol 2002;17:677-681
42. Arase Y, Suzuki F, Suzuki Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 2009;49:739-744
43. Sim ó R, Lecube A, Genesc à J, et al. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care 2006;29:2462-2466
44. Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes:effect of liver transplantation. Hepatology 2000;31:694-703.
45. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease:a feature of the metabolic syndrome. Diabetes 2001;50:1844-1850
46. Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001;7:608-614
47. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956
48. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas:appreciably high rates during a long-term follow-up. Hepatology 2007;45:1187-1192
49. Uetake S, Yamauchi M, Itoh S, et al. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen-and anti-HCV antibodynegative alcoholic cirrhosis:clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 2003;27 (8 Suppl):47S-51S.
50. D'Arienzo A, Manguso F, Scaglione G, et al. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol 1998;33:1213-1218